Mitoxantrone and VP-16 in refractory acute myelogenous leukemia.
Ho
A D
AD
Lipp
T
T
Ehninger
G
G
Meyer
P
P
Freund
M
M
Illiger
H J
HJ
Körbling
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D012074:Remission Induction
D005047:Etoposide; D008942:Mitoxantrone